Skip to main content
. 2013 Oct 14;8(10):e77240. doi: 10.1371/journal.pone.0077240

Table 4. Treatment-related adverse effects.

S-M S-LRTs P
Major adverse effects of grade 2 or more
HFSR 52 (23.0) 15 (23.4) NS
Diarrhea 37 (16.4) 10 (15.6) NS
Skin eruption 17 (7.5) 7 (10.9) NS
Anorexia 10 (4.4) 8 (12.5) 0.034
Abdominal pain 19 (8.4) 8 (12.5) NS
Sorafenib discontinuation due to adverse effects 64 (28.3) 19 (29.7) NS

Abbreviations: S-M, sorafenib monotherapy; S-LRTs, sorafenib combined with loco-regional treatments; HFSR, hand foot-skin reaction; NS, not significant.